Annual review | The top ten explosive stocks in the US stock market for 2024 have been released! Applovin emerges as the dark horse of the year in AI, MSTR astonishes the market with a fivefold increase for the year, and Tesla makes a comeback in the last
As of the market close on December 11, the S&P 500 Index has risen by 27% year-to-date, surpassing 6,000 points; the Nasdaq Composite Index has accumulated a rise of over 33%, reaching a milestone of 0.02 million points, exceeding market expectations.
Natera Announces Enrollment Of First Patients In SAGITTARIUS A Randomized Phase III Clinical Trial In Colon Cancer; ~700-900 Patients Expected To Be Enrolled Across More Than 20 Sites
2025 Investment Themes: AI, Energy, Defense Redefine US Markets
Price Over Earnings Overview: Penumbra
12 Analysts Assess Penumbra: What You Need To Know
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Illumina Analyst Ratings
$1000 Invested In Intuitive Surgical 15 Years Ago Would Be Worth This Much Today
Penumbra Analyst Ratings
SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
(ISRG) - Analyzing Intuitive Surgical's Short Interest
Intuitive Surgical Analyst Ratings
Goldman Sachs Downgrades Veracyte to Neutral, Lowers Price Target to $37
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
The hidden winner in the USA election? Cathie Wood's ARKK hit a new high for the year, all thanks to these heavily weighted stocks!
The strong rise of ARKK is mainly attributed to the increase in its heavy holdings, Tesla, and cryptos-related companies, Coinbase and Robinhood.
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Looking Into Natera's Recent Short Interest